2021
Merkel Cell Carcinoma: Changing Practice Patterns and Impact on Recurrence-Free and Overall Survival at a Single Institution and Nationally
Esposito A, Jacobs D, Ariyan S, Galan A, Kluger H, Clune J, Weiss S, Tran T, Olino K. Merkel Cell Carcinoma: Changing Practice Patterns and Impact on Recurrence-Free and Overall Survival at a Single Institution and Nationally. Annals Of Surgical Oncology 2021, 29: 415-424. PMID: 34494169, PMCID: PMC8677689, DOI: 10.1245/s10434-021-10727-2.Peer-Reviewed Original ResearchConceptsDisease-specific survivalOverall survivalCT2 diseasePractice patternsSingle-institution retrospective reviewShorter disease-specific survivalActive cigarette smokersAdoption of immunotherapyMultivariable Cox regressionUse of immunotherapyUse of radiotherapyResultsOne hundred fiftyShorter overall survivalAggressive neuroendocrine carcinomaRisk of mortalitySurrogate outcome measureBackgroundMerkel cell carcinomaTreatment of MCCMCC managementImmunocompromised stateMCC patientsMedian ageUnknown primaryRetrospective reviewCigarette smokers
2015
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ, Initiative A. Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014. Alzheimer's & Dementia 2015, 11: 865-884. PMID: 26194320, PMCID: PMC4659407, DOI: 10.1016/j.jalz.2015.04.005.Peer-Reviewed Original ResearchConceptsAlzheimer's Disease Neuroimaging InitiativeClinical trialsDisease Neuroimaging InitiativeAlzheimer's diseaseAD clinical trialsSurrogate outcome measureAD risk factorsTraumatic brain injuryPost-traumatic stress disorderAD risk allelesMultiple sclerosisRisk factorsBrain injuryAD progressionOutcome measuresEffective treatmentParkinson's diseaseImaging ligandsMilitary populationStress disorderRisk allelesDiseaseMultiple centersBiomarkersStandardized biomarkers
1996
Differences in the Incidence of Hepatitis B and Human Immunodeficiency Virus Infections among Injecting Drug Users
Levine O, Vlahov D, Brookmeyer R, Cohn S, Nelson K. Differences in the Incidence of Hepatitis B and Human Immunodeficiency Virus Infections among Injecting Drug Users. The Journal Of Infectious Diseases 1996, 173: 579-583. PMID: 8627020, DOI: 10.1093/infdis/173.3.579.Peer-Reviewed Original ResearchConceptsHepatitis B virusHBV seroconversionOutcome measuresDrug usersHuman immunodeficiency virus type 1 (HIV-1) seroconversionIncident hepatitis B virusHuman immunodeficiency virus (HIV) infectionHIV seroconversion ratesHIV-seronegative IDUsSubsequent HIV seroconversionImmunodeficiency virus infectionInjecting Drug UsersSurrogate outcome measureImportant outcome measureNeedle exchange programsMale IDUsHIV seroconversionIncident HIVSeroconversion ratesHepatitis BHIV infectionFemale IDUsB virusVirus infectionSeroconversion
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply